✦ LIBER ✦

P-42 Cisplatin/docetaxel (CDDP/TXT) as second-line treatment in advanced non-small cell lung cancer (NSCLC) patients pretreated with non-platinum-based regimens

✍ Scribed by Prochilo, Tiziana; Cafferata, Mara A.; Baldini, Editta; Ardizzoni, Andrea

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-542 Carboplatin (C) and docetaxel (D)

✍ Numico, G.; Buffoni, L.; Dongiovanni, V.; Schena, M.; Fissore, C.; Fea, E.; Occe 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 175 KB

794 Weekly paclitaxel (W-PAC) as second-

✍ G.L. Ceresoli; V. Gregorc; S. Cordio; K. Bencardino; A. Spreafico; C. Cozzarini; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

P-462 French practitioner survey on seco

✍ Breton, J.; Robinet, G.; Dansin, E.; Le Groumellec, A.; Dourthe, L.; Payrard, S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Cisplatin and irinotecan (CPT-11) as sec

✍ Kakolyris, S; Kouroussis, Ch; Souglakos, J; Agelaki, S; Kalbakis, K; Vardakis, N 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 79 KB

P-7 Docetaxel as second-line chemotherap

✍ Barradas, Pedro S.; Oliveira, Ana S.; Costa, Agostino S.; Figueiredo, Ana M.; Al 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Phase II study of docetaxel (DOC) and ca

✍ van Putten, J.W.G; Slebos, D.J; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB